Rising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...

With an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...

India's drug pricing authority has approved a 50% price hike for essential anti-cancer drugs carboplatin and cisplatin. This decision follo...

Precision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...

As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...

Tata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...

The Indian Patent Office has denied a secondary patent for AbbVie's Hepatitis C drug Maviret. This decision ensures continued access to aff...

Pfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...

Roche Pharma India introduces a new injectable immunotherapy for lung cancer. This treatment takes only seven minutes, a significant reduct...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

Local drug manufacturers are struggling to produce essential cancer medicines like carboplatin and cisplatin due to a significant surge in ...

The government has significantly reduced GST rates on 41 highly priced medicines, including those for cancer, rare diseases, and heart cond...

A parliamentary panel has urged for broader price controls on cancer drugs, noting that many remain unaffordable. The committee recommends ...

Drug firm Eli Lilly and Company India today said it has entered into branded generics segment in the country with the launch of four cancer...

A superior option is for the government to impose price controls on expensive drugs, whether imported or produced domestically.

The government is in talks with drugmakers for sourcing medicines to treat cancer at a discount to be sold at its low-cost pharmacy chain J...

Pharma powerhouse Cipla has started talks with the government to share knowledge on making cancer drugs, which, if successful, could radica...